Biotech

All Articles

Actinogen reports brand-new stage 2 records to restore depression medication

.Actinogen Medical's hopes-- and also supply price-- have rebounded slightly coming from earlier thi...

Pfizer and Front runner add Quotient to multibillion-dollar equation

.Front Runner Pioneering and Pfizer have included Quotient in to their 10-program partnership, inkin...

Bayer pens $547M treaty to drive limits of noncoding RNA

.Bayer execs were interested to tension to Tough this summer months that the German pharma giant's c...

UK reveals strategies to release 18 brand-new professional trial centers

.Amidst a yearslong scientific trial decline in the U.K., a brand-new public-private alliance has ac...

UPDATE: Genentech telegrams 93 unemployments in The golden state after sharing programs to shutter cancer immunology research study unit

.Observing the statement of a big discharge round in April and a primary rebuilding project revealed...

Neurocrine's KarXT rival strikes in stage 2-- yet only at reduced dosage

.Neurocrine Biosciences has achieved its own hoped-for profile page in a stage 2 schizophrenia trial...

Vaderis' unusual blood vessel disorder medication decreases nosebleeds

.Vaderis Rehabs' target to build the 1st medication aimed specifically at a certain unusual capillar...

Navigator rears $100M to cultivate brand new autoimmune pipeline

.Sat nav Medicines has outfitted itself with $100 million in collection A funds as the youthful biot...

Duality looks for cash for ADC trials as IPO wave infects Asia

.China's Duality Biotherapeutics has actually filed (PDF) documents for a Hong Kong IPO, looking for...

YolTech sells China liberties to gene editing and enhancing therapy for $29M

.4 months after Chinese genetics editing and enhancing firm YolTech Therapies took its own cholester...